Are smokers more likely to develop severe symptoms with COVID-19?
Andrew Mclaughlin
Updated on March 01, 2026
Current evidence suggests that the severity of COVID-19 disease is higher among smokers. Smoking impairs lung function, making it more difficult for the body to fight off respiratory disease due to the new coronavirus.Tobacco users have a higher risk of being infected with the virus through the mouth while smoking cigarettes or using other tobacco products. If smokers contract the COVID-19 virus, they face a greater risk of getting a severe infection as their lung health is already compromised.
What happens if your C reactive protein is high?
High levels may point to inflammation in the arteries of the heart. This can increase someone’s risk of having a heart attack or developing other cardiac problems, such as coronary artery disease, arteriosclerosis or stroke. What is a C-reactive protein test used for?
What is the abbreviation for C-reactive protein?
C-reactive protein (CRP) was identified in 1930 and was subsequently considered to be an “acute phase protein,” an early indicator of infectious or inflammatory conditions. Since its discovery, CRP has been studied as a screening device for inflammation, a marker for disease activity, and as a diagn …
Is C-reactive protein an early indicator of infectious or inflammatory conditions?
DOI: 10.1016/s0736-4679(99)00135-3 Abstract C-reactive protein (CRP) was identified in 1930 and was subsequently considered to be an “acute phase protein,” an early indicator of infectious or inflammatory conditions.
Should C-reactive protein be included in screening tests for cardiovascular disease?
Currently, C-reactive protein is not recommended as a cardiovascular disease screening test for average-risk adults without symptoms. The American Heart Association and U.S. Centers for Disease Control and Prevention have defined risk groups as follows: Low Risk: less than 1.0 mg/L Average risk: 1.0 to 3.0 mg/L